نتائج البحث - "Sjoerd Hovenga"

1

No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status

المؤلفون: Nic J. G. M. Veeger, Bart Klijs, Eric N. van Roon, Bas P. van Rees, Huib Storm, Hanneke C. Kluin-Nelemans, Gerhard Woolthuis, Karin Boslooper, Sjoerd Hovenga, Robby E. Kibbelaar, Geertruida H. de Bock, Mels Hoogendoorn

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Stem Cell Aging Leukemia and Lymphoma (SALL), Life Course Epidemiology (LCE), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

المصدر: Cancer epidemiology, 48, 110-116. ELSEVIER SCI LTD

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, IMPACT, Epidemiology, NETHERLANDS, POPULATION-BASED COHORT, Population, Population-based, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, 030212 general & internal medicine, education, ELDERLY-PATIENTS, Socioeconomic status, Aged, education.field_of_study, Performance status, business.industry, MORTALITY, Hazard ratio, Middle Aged, medicine.disease, Survival Analysis, CANCER, Comorbidity, Surgery, Social Class, Oncology, DLBCL, 030220 oncology & carcinogenesis, DENMARK, Cohort, SURVIVAL, INEQUALITIES, Female, Lymphoma, Large B-Cell, Diffuse, NON-HODGKIN-LYMPHOMA, business, Diffuse large B-cell lymphoma, Cohort study

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e587582d786676305cac84f9cdb3c915
https://doi.org/10.1016/j.canep.2017.04.009

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

2

The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study

المؤلفون: Sjoerd Hovenga, de Esther Waal, Gerhard Woolthuis, Mels Hoogendoorn, van Eric Roon, Huib Storm, Robby E. Kibbelaar, Berdien Oortgiesen, Nic J. G. M. Veeger, Peter Joosten, B van Rees

المساهمون: PharmacoTherapy, -Epidemiology and -Economics, Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)

المصدر: European Journal of Clinical Pharmacology, 73(6), 771-778. Springer Verlag

مصطلحات موضوعية: Male, Melphalan, Cohort Studies, 0302 clinical medicine, Risk Factors, Prednisone, Medicine, Overall survival, Pharmacology (medical), Prospective Studies, Registries, Multiple myeloma, Netherlands, Aged, 80 and over, education.field_of_study, Age Factors, General Medicine, Clinical parameters, Middle Aged, DEXAMETHASONE, Survival Rate, 030220 oncology & carcinogenesis, Female, Kidney Diseases, Multiple Myeloma, medicine.drug, Cohort study, PREDNISONE, Adult, medicine.medical_specialty, Hypercalcaemia, Novel agents, Population, IMPROVEMENT, Antineoplastic Agents, DIAGNOSIS, Population-based registry, 03 medical and health sciences, AGE, Internal medicine, Humans, THALIDOMIDE, education, Aged, Pharmacology, business.industry, LONG-TERM SURVIVAL, B-CELL LYMPHOMA, medicine.disease, Comorbidity, Surgery, Thalidomide, Multivariate Analysis, MELPHALAN, PATTERNS, Hypercalcemia, business, Follow-Up Studies, 030215 immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97aa7fc002a89a5774166632a706c13b
https://doi.org/10.1007/s00228-017-2227-1

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

3

Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands

المؤلفون: Max Beijert, Edo Vellenga, Sjoerd Hovenga, W.M. Smit, Hanneke J. Vos, Marnix J. Leene, Nic J. G. M. Veeger, Marieke Hogenes, Mels Hoogendoorn, Esther G. M. de Waal, Arjan Diepstra, Francisca Ong

المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: British Journal of Haematology, 175(4), 661-667. Wiley

مصطلحات موضوعية: 0301 basic medicine, Male, Vascular Endothelial Growth Factor A, Pathology, Angiogenesis, Biopsy, Kaplan-Meier Estimate, GUIDELINES, Gastroenterology, Multimodal Imaging, chemistry.chemical_compound, angiogenesis, 0302 clinical medicine, Basic Helix-Loop-Helix Transcription Factors, Registries, Multiple myeloma, Netherlands, extramedullary plasmacytoma, Aged, 80 and over, solitary plasmacytoma of the bone, education.field_of_study, OUTCOMES, medicine.diagnostic_test, Hematology, Middle Aged, Immunohistochemistry, Vascular endothelial growth factor, multiple myeloma, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, Population Surveillance, Monoclonal, Disease Progression, Female, Adult, medicine.medical_specialty, micro vessel density, BONE-MARROW, Population, DIAGNOSIS, 03 medical and health sciences, Internal medicine, medicine, Humans, education, Aged, Proportional Hazards Models, Retrospective Studies, business.industry, medicine.disease, Hypoxia-Inducible Factor 1, alpha Subunit, 030104 developmental biology, chemistry, Plasmacytoma, Bone marrow, business, Biomarkers, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfd75f13ff57cfa96e983c5e05661bc
https://doi.org/10.1111/bjh.14291

View record at Wiley

4

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

المؤلفون: Andrzej Piwowar, Fransje Aa Valster, Jeffrey P.B.M. Braak, Marije Ie Appels, Frits van Coevorden, Niels H Nielsen, Johanna E.A. Portielje, Jeroen Buijsen, Petra Flygare, Marije Slingerland, Nicole C.T. van Grieken, Jetske M. Meerum Terwogt, Maartje Los, Mattias Elmlund, Henk Boot, Rob L. H. Jansen, Johanna W. van Sandick, A. Haringhuizen, Johannes J. Bonenkamp, Harm van Tinteren, Edwin P.M. Jansen, Henk H. Hartgrink, Jaap De Boer, Anouk K. Trip, Ge Jpm Jonkers, Marie Louise Jespersen, Cecillia Lagerbäck, Per Edlund, Marco B Polée, Mats Perman, J (Hans)-Martin Mb Otten, Marjan A Van Dijk, Danny Houtsma, A (Bert) Jan Ten Tije, Arnold Baars, Olaf Jl Loosveld, Maud M. Geenen, Maarten C.C.M. Hulshof, Gerrit-Jan Veldhuis, Erik W Muller, Geert-Jan Creemers, Annelie Je Vulink, Quirijn A. J. Eijsbouts, Annerie Slot, Diane Grootenboers, Hein Putter, Ellen M Hendriksen, Maurice J.C. van der Sangen, Fabiënne A. R. M. Warmerdam, Tom Rozema, HA A. Maurits Swellengrebel, Henk K Van Halteren, Ate van der Gaast, Marcel Verheij, Richard Van Hilligersberg, Helene Hörberg, Pehr Lind, Annemieke Cats, Cornelis J.H. van de Velde, Jitty M Smit, Alex L. T. Imholz, Donald L. van der Peet, Aart Van Bochove, Henk M.W. Verheul, Adelheid Me Van der Torren-Conze, Frans L. G. Erdkamp, Dick Johan van Spronsen, Mark I. van Berge Henegouwen, Ernst Jan Spillenaar Bilgen, Johanna Mgh Van Riel, Marien O Den Boer, Hanneke W. M. van Laarhoven, Marjolein Em Rentinck, Ron C Rietbroek, Bengt Johansson, David Borg, Anders Johnsson, Aart Beeker, Reinoud J. B. Blaisse, Miriam Koopman, Daan Ten Bokkel Huinink, Karen J. Neelis, Elma Meershoek-Klein Kranenbarg, Djamila Boerma, Heleen M. Ceha, Bea C Tanis, Marie-Cecile Jc Legdeur, O Aart Van Dobbenburgh, Steven Vanhoutvin, Sjoerd Hovenga, Karolina Sikorska, Pètra M Braam, H Pieter van den Berg, Huub van der Mijle, Marianne Nordsmark, Bengt Glimelius

المساهمون: Oncology, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Surgery, Radiotherapy, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde, Pathology, CCA - Cancer Treatment and quality of life, VU University medical center, Radiation Oncology, AGEM - Digestive immunity, Medical oncology, Plastic, Reconstructive and Hand Surgery

المصدر: lancet oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group

مصطلحات موضوعية: Male, 0301 basic medicine, Time Factors, medicine.medical_treatment, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, I-II, education.field_of_study, Middle Aged, Neoadjuvant Therapy, Progression-Free Survival, Europe, GASTROESOPHAGEAL JUNCTION, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Epirubicin, medicine.drug, medicine.medical_specialty, Population, Adenocarcinoma, Sudden death, Medication Adherence, CISPLATIN, 03 medical and health sciences, Gastrectomy, Stomach Neoplasms, medicine, DOSE-ESCALATION, Humans, Progression-free survival, CAPECITABINE CHEMOTHERAPY, education, Aged, Neoplasm Staging, Chemotherapy, III TRIAL, Performance status, business.industry, PERIOPERATIVE CHEMOTHERAPY, Chemoradiotherapy, Adjuvant, Surgery, Oxaliplatin, 030104 developmental biology, NODAL DISSECTION, Quality of Life, Lymph Node Excision, Dose Fractionation, Radiation, business, POSTOPERATIVE CHEMORADIOTHERAPY, Chemoradiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21019f3b155741c37a17771cdb957cb
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

5

Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome

المؤلفون: Bas P. van Rees, Eric N. van Roon, Elly de Graaf, Gerhard Woolthuis, Nic J. G. M. Veeger, Karin Boslooper, Mels Hoogendoorn, Hanneke C. Kluin-Nelemans, Robby E. Kibbelaar, Huib Storm, Sjoerd Hovenga, Peter Joosten

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Life Course Epidemiology (LCE), Stem Cell Aging Leukemia and Lymphoma (SALL)

المصدر: Leukemia and Lymphoma, 55(3), 526-532. TAYLOR & FRANCIS LTD

مصطلحات موضوعية: Male, Oncology, CHOP CHEMOTHERAPY, Cancer Research, medicine.medical_treatment, THERAPY, Cohort Studies, Antibodies, Monoclonal, Murine-Derived, Elderly, Prednisone, Cause of Death, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Registries, Aged, 80 and over, education.field_of_study, COMPREHENSIVE GERIATRIC ASSESSMENT, Age Factors, Hematology, COLONY-STIMULATING FACTOR, SOLID TUMORS, CANCER, Treatment Outcome, Vincristine, Prednisolone, Female, TRIAL, Rituximab, Lymphoma, Large B-Cell, Diffuse, medicine.drug, medicine.medical_specialty, Cyclophosphamide, Population, NEUTROPENIA, Internal medicine, medicine, Humans, NON-HODGKINS-LYMPHOMA, education, Aged, Neoplasm Staging, OLDER, Chemotherapy, business.industry, medicine.disease, HemoBase, population-based, Surgery, Doxorubicin, DLBCL, business, Diffuse large B-cell lymphoma, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::830dfcd397b3620ede45dacd0fcecd92
https://doi.org/10.3109/10428194.2013.810737

PDF full text from Publisher

6

Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance

المؤلفون: Sjoukje F. Oosting, Sjoerd Hovenga, Harry J. F. Semmelink, Arjen R. Mensenkamp, R. Jeroen A. van Moorselaar, Fred H. Menko, Sadhanna Badeloe, Karin Y. van Spaendonck-Zwarts, Jan Hein T.M. van Waesberghe

المساهمون: Urology, Radiology and nuclear medicine, Human genetics, CCA - Innovative therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Familial Cancer, 11(1), 123-129. Springer Netherlands
Familial Cancer, 11(1), 123-129. SPRINGER
Familial Cancer
van Spaendonck-Zwarts, K Y, Badeloe, S, Oosting, S F, Hovenga, S, Semmelink, H J F, van Moorselaar, R J A, van Waesberghe, J H T M, Mensenkamp, A R & Menko, F H 2012, ' Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance ', Familial Cancer, vol. 11, no. 1, pp. 123-129 . https://doi.org/10.1007/s10689-011-9491-5
Familial Cancer, 11, 123-9
Familial Cancer, 11, 1, pp. 123-9

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Pathology, Cancer Research, Adolescent, CARCINOMA, urologic and male genital diseases, AGGRESSIVE FORM, PATIENT, HLRCC, FH, FAMILIES, Diagnosis, Differential, TUMOR SYNDROME, Leiomyomatosis, Germline mutation, Internal medicine, Epidemiology, Carcinoma, medicine, Genetics, Humans, Genetic Predisposition to Disease, Genetics(clinical), Papillary renal cancer, FUMARATE-HYDRATASE, UTERINE LEIOMYOMATA, Carcinoma, Renal Cell, Genetics (clinical), Hereditary leiomyomatosis, Translational research Genomic disorders and inherited multi-system disorders [ONCOL 3], business.industry, Cancer, HYDRATASE GERMLINE MUTATION, Prognosis, medicine.disease, Kidney Neoplasms, Human genetics, Pedigree, Review Literature as Topic, Female, Original Article, Cell cancer, Differential diagnosis, business, Fumarate hydratase